Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2025 is 0.28% vs 0.56% in Mar 2024
Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods;
Fixed Assets
YoY Growth in year ended Mar 2025 is -8.98% vs -10.51% in Mar 2024
Investments
No Investments in the last few periods;
Current Assets
YoY Growth in year ended Mar 2025 is 3.26% vs 24.80% in Mar 2024
Compare Balance Sheet Results of Norris Medicines
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
9.93
0.62
9.31
1,501.61%
Share Warrants & Outstandings
Total Reserve
-24.79
-2.70
-22.09
-818.15%
Shareholder's Funds
-14.87
-2.08
-12.79
-614.90%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
18.53
0.84
17.69
2,105.95%
Secured Loans
0.00
0.00
0.00
0.00%
Unsecured Loans
18.53
0.84
17.69
2,105.95%
Deferred Tax Assets / Liabilities
-0.90
0.00
-0.90
0.00%
Other Long Term Liabilities
0.00
2.87
-2.87
-100.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.00
0.28
-0.28
-100.00%
Total Non-Current Liabilities
17.62
3.99
13.63
341.60%
Current Liabilities
Trade Payables
2.57
0.75
1.82
242.67%
Other Current Liabilities
1.79
2.69
-0.90
-33.46%
Short Term Borrowings
3.05
0.00
3.05
0.00%
Short Term Provisions
2.74
0.37
2.37
640.54%
Total Current Liabilities
10.15
3.81
6.34
166.40%
Total Liabilities
12.91
5.72
7.19
125.70%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
27.76
0.97
26.79
2,761.86%
Less: Accumulated Depreciation
22.49
0.91
21.58
2,371.43%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
5.27
0.06
5.21
8,683.33%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
0.00
0.00
0.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.01
0.01
0.00
0.00%
Long Term Loans & Advances
1.29
3.59
-2.30
-64.07%
Other Non Current Assets
0.00
0.00
0.00
0.00%
Total Non-Current Assets
6.57
3.66
2.91
79.51%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
4.13
0.10
4.03
4,030.00%
Sundry Debtors
1.41
1.76
-0.35
-19.89%
Cash and Bank
0.04
0.12
-0.08
-66.67%
Other Current Assets
0.74
0.03
0.71
2,366.67%
Short Term Loans and Advances
0.02
0.05
-0.03
-60.00%
Total Current Assets
6.34
2.06
4.28
207.77%
Net Current Assets (Including Current Investments)
-3.81
-1.75
-2.06
-117.71%
Total Current Assets Excluding Current Investments
6.34
2.06
4.28
207.77%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
12.91
5.72
7.19
125.70%
Contingent Liabilities
1.33
0.21
1.12
533.33%
Total Debt
21.58
0.84
20.74
2,469.05%
Book Value per share (adjusted)
-14.98
-33.26
18.28
54.96%
Annual - Borrowings
Borrowings 21.58 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 0.28% vs 0.56% in Mar 2024
Annual - Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods
No Other Long Term Liabilities in the last few periods;
Annual - Fixed Assets
Fixed Assets 5.27 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -8.98% vs -10.51% in Mar 2024
Annual - Investments
Investments 0.01 Cr
in Mar 2025Figures in Cr
No Investments in the last few periods;
Annual - Current Assets
Current Assets 6.34 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 3.26% vs 24.80% in Mar 2024






